Skip to content
← Back to this collection

PUBLICATIONS · 31765002

Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cochrane Database Syst Rev
Publication date
2019 Nov 25
First author
Piechotta V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Piechotta V
      type
      Author
    2. name
      Jakob T
      type
      Author
    3. name
      Langer P
      type
      Author
    4. name
      Monsef I
      type
      Author
    5. name
      Scheid C
      type
      Author
    6. name
      Estcourt LJ
      type
      Author
    7. name
      Ocheni S
      type
      Author
    8. name
      Theurich S
      type
      Author
    9. name
      Kuhr K
      type
      Author
    10. name
      Scheckel B
      type
      Author
    11. name
      Adams A
      type
      Author
    12. name
      Skoetz N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Piechotta V
      type
      Author
    2. name
      Jakob T
      type
      Author
    3. name
      Langer P
      type
      Author
    4. name
      Monsef I
      type
      Author
    5. name
      Scheid C
      type
      Author
    6. name
      Estcourt LJ
      type
      Author
    7. name
      Ocheni S
      type
      Author
    8. name
      Theurich S
      type
      Author
    9. name
      Kuhr K
      type
      Author
    10. name
      Scheckel B
      type
      Author
    11. name
      Adams A
      type
      Author
    12. name
      Skoetz N
      type
      Author
    bibliography ids
    1. nci-bib-28dc737ebeed227d3a1a3c7d
    book metadata
    content sha256
    99310a715acdcdf0f29c62799866c09155d654b67136a22d93a101ede5a3da8c
    document type
    citation
    dois
    1. 10.1002/14651858.CD013487
    electronic publication date
    display
    2019 Nov 25
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31765002
    immutable id
    pubmed:31765002@99310a715acdcdf0f29c62799866c09155d654b67136a22d93a101ede5a3da8c
    journal
    abbreviation
    Cochrane Database Syst Rev
    issn electronic
    1469-493X
    issn print
    1361-6137
    issue
    11
    name
    The Cochrane database of systematic reviews
    nlm unique id
    100909747
    pages
    Source null
    volume
    2019
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31765002
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      ac0f5b5d4db188917a7de4554057ed956fc6d351b31cf8b10bda2dce79c2009c
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2019 Nov 25
      precision
      day
      year
      2019
      publication types
      1. Journal Article
      2. Systematic Review
      3. Network Meta-Analysis
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31765002/
      title
      Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.

      Preserved source evidence · Not medical advice